Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN108623598A details improved Imipenem synthesis reducing impurities and enhancing crystallinity for reliable pharmaceutical intermediate supply chains.
Patent CN112409235A details a Rh-catalyzed asymmetric hydrogenation route for chiral 4-halogenated tryptophan derivatives with 99.9% ee, offering a scalable solution for API intermediates.
Patent CN113789527B reveals a metal-free electrochemical route for aromatic amines, offering green synthesis and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN101921229B details a novel asymmetric catalytic hydrogenation route for L-Stepholidine. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN107141325A reveals novel astilbin derivatives improving bioavailability. Reliable supplier for scalable pharmaceutical intermediates manufacturing.
Patent CN109096329B details a novel asymmetric transfer hydrogenation for chiral beta-hydroxy phosphates, offering cost-effective routes for pharmaceutical intermediates.
Discover a safer, high-yield synthesis for Edoxaban intermediates via Diels-Alder cyclization. Eliminate sodium azide risks and reduce manufacturing costs with our scalable process.
Patent CN104402878A details high-purity Imiquimod production. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel catalytic dehydrogenation route for 2-indol-3-yl-quinolines offers high purity and scalable manufacturing for global pharmaceutical intermediates supply chains.
Patent CN110305025B details a green photocatalytic method for benzylamine synthesis using Eosin Y and water, offering significant cost and safety advantages for pharmaceutical intermediates.
Patent CN113636968B details a novel ruthenium-catalyzed route for 3-acylpyrroles, offering superior atom economy and simplified purification for pharmaceutical manufacturing.
Novel route for (R)-2-(2,5-difluorophenyl)pyrrolidine avoids noble metals, offering cost-effective API manufacturing solutions.
Patent CN108409651B details a novel hydrogenation method converting chloroquinaldine waste into high-purity 8-hydroxy-2-methylquinoline, offering significant cost reduction and supply chain reliability.
Novel Raney Nickel catalytic method reduces energy and solvent costs for pharmaceutical intermediate manufacturing supply chain efficiency and high purity output.
Patent CN115286504B details asymmetric hydrogenation for brivaracetam intermediate. Delivers high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN115322106B details a novel high-selectivity synthesis route. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable, mild conditions.
Patent CN113999201A details a novel asymmetric synthesis of S-nicotine, offering high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN110724164B details novel pyridine-substituted spiro ligands enabling high TON hydrogenation. Ideal for API intermediates.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Novel Rh-catalyzed asymmetric hydrogenation avoids resolution, boosting yield to 42.55% for reliable API intermediate supply.